Trial Profile

Randomized, double-blind, placebo-controlled, phase 1, first-in-human, single and multiple ascending dose trial evaluating safety and pharmacokinetic effects of the oral TLC-3595 in healthy volunteers

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 09 Nov 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

09 Nov 2022 New trial record
08 Nov 2022 Results assessing safety and pharmacokinetics of TLC-3595 in healthy volunteers, presented at The Liver Meeting 2022: 73rd Annual Meeting of the American Association for the Study of Liver Diseases.
02 Nov 2022 According to an OrsoBio, Inc media release, this study data support to initiate phase 2a study.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com